ossifying fibroma: A bone benign neoplasm that is located_in the mouth and results_in an overgrowth of gingival tissue due to irritation or trauma.
Benign neoplasm: Other and unspecified parts of mouth
CD2_BENIGN_MOUTH_NOS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1240 |
4. Check minimum number of eventsNone |
1240 |
5. Include endpointsNone |
1240 |
6. Filter based on genotype QC (FinnGen only) |
1240 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10
- Name in latin
- Neoplasma benignum partium oris aliarum sive non specificatarum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Other and unspecified parts of mouth
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Other and unspecified parts of mouth
- Benign neoplasm of mouth and pharynx
- Benign neoplasm of mouth and pharynx
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 8787 | 4911 | 3828 |
| Only index persons | 8081 | 4588 | 3493 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.13 | 0.14 | 0.11 |
| Only index persons | 0.15 | 0.17 | 0.13 |
| Median age at first event (years) | |||
| Whole population | 54.40 | 55.07 | 53.48 |
| Only index persons | 53.69 | 54.56 | 52.55 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1240 | 698 | 542 |
| Unadjusted period prevalence (%) | 0.24 | 0.24 | 0.24 |
| Median age at first event (years) | 56.65 | 55.66 | 57.94 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1123
- Matched controls
- 11227
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.39
ICD-10 Finland
Benign tumor in other or unspecified part of oral cavity UNS
+∞
323.0
495
*
D10.30
ICD-10 Finland
Benign tumor of the mucous membrane of the cheek
+∞
287.1
263
*
D10.35
ICD-10 Finland
Benign tumor of the soft palate
+∞
122.1
115
*
EHA10
NOMESCO Finland
Biopsy of palate
83.1
113.1
126
17
D10.34
ICD-10 Finland
Benign tumor of the hard palate
361.2
98.7
98
*
EKA10
NOMESCO Finland
Biopsy of cheek
15.8
77.7
130
92
EKB00
NOMESCO Finland
Excision of lesion of cheek
58.0
69.0
81
15
EHB00
NOMESCO Finland
Excision of lesion of palate
89.0
60.6
67
8
21049
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Other and unspecified parts of mouth
+∞
56.7
54
*
D10.36
ICD-10 Finland
Benign tumor of the uvula
+∞
50.4
48
*
ENA10
NOMESCO Finland
Biopsy of pharynx
50.4
44.2
53
11
D10.33
ICD-10 Finland
Bone tumor in the gums
+∞
38.8
37
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
9.1
37.1
80
94
D10.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of mouth
+∞
26.1
25
*
2104A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Other and unspecified parts of mouth
+∞
23.0
22
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
4.6
19.9
70
159
EAA10
NOMESCO Finland
Excision of lesion of lip
8.6
19.0
41
49
SXA10
NOMESCO Finland
Epithel biopsy of mouth
9.8
19.0
38
40
ECA20
NOMESCO Finland
Biopsy of gingiva
9.8
18.5
37
39
A07AA02
ATC
nystatin; oral
3.2
17.8
96
317
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
17.5
385
2498
SAA03
NOMESCO Finland
Extended examination of mouth
1.8
17.2
436
2958
K13.78
ICD-10 Finland
Other change in the oral mucosa
6.0
16.8
46
79
C05.1
ICD-10 Finland
Malignant neoplasm: Soft palate
+∞
16.7
16
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.0
15.1
89
312
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
81.2
14.6
16
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
5.9
13.8
38
66
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.2
13.3
138
664
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.8
13.1
84
311
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.0
12.9
74
255
EMA10
NOMESCO Finland
Biopsy of tonsil
22.8
12.9
18
8
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.0
12.6
72
247
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.9
12.6
75
266
C05.0
ICD-10 Finland
Malignant neoplasm: Hard palate
+∞
12.5
12
*
D20
ICPC
Mouth/tongue/lip symptom/complaint
3.1
12.5
68
227
WX110
NOMESCO Finland
Local anesthesy
1.6
12.2
734
6090
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
4.3
12.1
44
105
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
12.1
302
1999
J01DB01
ATC
cefalexin; oral
1.7
11.3
880
7710
R06.0
ICD-10 Finland
Dyspnoea
1.7
11.1
265
1724
K13.29
ICD-10 Finland
Indefinite leukoplakia
6.0
10.9
29
49
R01AD09
ATC
mometasone; nasal
1.5
10.9
469
3554
E0000UV
ATC
NA
1.6
10.7
412
3033
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
11.3
10.6
19
17
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
10.1
294
2011
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
11.4
10.1
18
16
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
10.1
251
1649
GBB00
NOMESCO Finland
Tracheostomy
6.5
10.0
25
39
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
10.1
10.0
19
19
A02BC02
ATC
pantoprazole; systemic
1.5
10.0
692
5783
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
5.6
10.0
28
51
J37.0
ICD-10 Finland
Chronic laryngitis
3.5
9.8
44
128
JDB10
NOMESCO Finland
Percutaneous gastrostomy
6.2
9.7
25
41
N03AX16
ATC
pregabalin; oral
1.7
9.7
253
1681
R13
ICD-10 Finland
Dysphagia
2.4
9.6
80
344
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
9.6
725
6153
J39.2
ICD-10 Finland
Other diseases of pharynx
7.2
9.5
22
31
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
9.5
190
1166
D10.32
ICD-10 Finland
Bone tumor in the cheek sulcus
+∞
9.4
9
*
J02AC01
ATC
fluconazole; systemic
1.5
9.3
400
2997
D10.5
ICD-10 Finland
Benign neoplasm: Other parts of oropharynx
18.8
8.9
13
7
R03AC02
ATC
salbutamol; inhalant
1.5
8.8
534
4291
R07.0
ICD-10 Finland
Pain in throat
2.5
8.8
67
277
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
8.8
421
3223
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.2
8.6
83
387
R01AD08
ATC
fluticasone; nasal
1.6
8.6
290
2047
ZXA00
NOMESCO Finland
Right side
1.6
8.6
295
2091
K11.69
ICD-10 Finland
Mukocele UNS
11.7
8.6
15
13
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
8.4
86
411
EFA10
NOMESCO Finland
Excision of lesion of jaws
90.7
8.4
9
*
D07AA02
ATC
hydrocortisone; topical
1.8
8.3
140
812
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
8.6
8.3
17
20
A01AB04
ATC
amphotericin B; local oral
2.6
8.3
60
242
ZXA05
NOMESCO Finland
Left side
1.6
8.2
276
1943
J01FF01
ATC
clindamycin; systemic
1.5
8.1
280
1988
H02AB06
ATC
prednisolone; systemic
1.4
8.0
477
3795
UJF32
NOMESCO Finland
Coloscopy
1.5
7.9
274
1942
K11.60
ICD-10 Finland
Ranula
13.1
7.9
13
10
A02BC05
ATC
esomeprazole; systemic
1.5
7.9
423
3294
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
45.3
7.7
9
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
7.6
100
532
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
3.4
7.6
35
106
EEB00
NOMESCO Finland
Partial excision of maxilla
25.2
7.6
10
*
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.1
7.5
86
430
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
7.5
355
2691
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
7.4
452
3596
SXC03
NOMESCO Finland
Other oral or dental procedure
5.6
7.4
20
36
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
2.6
7.4
49
190
R51.80
ICD-10 Finland
Headache
1.7
7.4
145
884
4322
FHL
Partial mucosal removal or cryo (biopsy, tumor, hyperplasty)
+∞
7.3
7
*
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
7.4
7.2
16
22
D37.09
ICD-10 Finland
Lip, oral cavity and pharynx
30.2
7.2
9
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
30.2
7.2
9
*
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
7.1
478
3863
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
7.1
417
3285
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
5.7
7.1
19
34
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
10.1
7.0
13
13
D07AB08
ATC
desonide; topical
1.9
7.0
106
591
J31.0
ICD-10 Finland
Chronic rhinitis
2.0
7.0
85
440
A02BC03
ATC
lansoprazole; oral
1.5
7.0
307
2285
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
6.9
199
1347
EBB10
NOMESCO Finland
Insertion of dental implant
4.4
6.9
23
53
N02BE01
ATC
paracetamol; systemic, rectal
1.5
6.8
914
8357
A01AB09
ATC
miconazole; local oral
1.9
6.8
97
531
N02AA05
ATC
oxycodone; systemic
1.7
6.8
140
866
8070/3-C06.0
ICD-O-3
Squamous cell carcinoma, NOS, of cheeck mucosa
40.3
6.8
8
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
40.3
6.8
8
*
J01AA02
ATC
doxycycline; systemic
1.4
6.7
825
7393
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
22.7
6.7
9
*
M79.1
ICD-10 Finland
Myalgia
1.7
6.6
129
785
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
4.6
6.6
21
46
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.5
6.6
47
190
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
6.6
296
2210
D07AC01
ATC
betamethasone; topical
1.4
6.5
345
2658
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
2.1
6.5
70
344
S29
ICPC
Skin symptom/complaint other
1.6
6.5
168
1106
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
6.5
372
2909
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
6.5
131
806
R06AE07
ATC
cetirizine; oral
1.4
6.5
430
3453
EBB15
NOMESCO Finland
Insertion of dental implant abutment
5.7
6.5
17
30
R03BB04
ATC
tiotropium bromide; inhalant
1.8
6.5
107
619
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.7
6.4
40
150
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
3.0
6.4
35
121
G47.3
ICD-10 Finland
Sleep apnoea
1.5
6.4
219
1541
J01CA04
ATC
amoxicillin; systemic
1.4
6.4
818
7345
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.4
430
3459
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
6.3
633
5445
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.8
6.3
37
134
D16.50
ICD-10 Finland
Benign tumor of the mandibular bone or cartilage
+∞
6.3
6
*
D10.37
ICD-10 Finland
Benign tumor in the retromolar area
+∞
6.3
6
*
D10.38
ICD-10 Finland
Benign tumor in maxilla tubes
+∞
6.3
6
*
D16.51
ICD-10 Finland
Benign tumor of the mandibular bone with urpsrung in teeth
+∞
6.3
6
*
C05.9
ICD-10 Finland
Malignant neoplasm: Palate, unspecified
+∞
6.3
6
*
J01FA09
ATC
clarithromycin; systemic
1.4
6.2
314
2394
N05BA01
ATC
diazepam; systemic, rectal
1.7
6.1
131
820
L43.8
ICD-10 Finland
Other lichen planus
3.5
6.1
26
75
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.0
6.1
74
384
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.6
6.1
143
919
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
578
4293
1.65
16.25
2.2
2.0
90.7
96.0
pmol/l
2.29
296
2224
907
7667
1.68
14.32
4.7
4.1
12.9
12.5
mm/h
0.40
836
7089
273
1723
1.75
13.77
3.2
2.7
1.3
1.1
e6/l
0.11
154
980
612
4747
1.57
13.47
6.7
6.0
1.2
1.2
mmol/l
0.35
544
4315
555
4218
1.57
13.30
2.3
2.2
77.6
77.6
nmol/l
0.01
499
3751
1125
10242
2.06
12.49
18.8
14.4
22.9
24.3
mg/l
0.83
946
8147
730
5978
1.54
12.00
11.0
9.2
4.3
4.1
e9/l
0.85
647
5246
650
5200
1.53
11.85
7.1
6.7
1.2
1.2
mmol/l
0.10
543
4413
251
1613
1.70
11.68
3.3
2.9
2.2
2.3
e6/l
0.09
134
871
572
4474
1.52
11.46
5.2
4.8
35.5
35.4
g/l
0.12
531
4158
207
1279
1.74
11.06
7.8
7.3
—
—
—
0
0
1037
9291
1.71
10.92
20.6
15.6
39.8
39.8
%
0.02
726
6553
1150
10639
2.12
10.87
21.1
16.6
139.6
139.7
mmol/l
0.41
1123
10370
467
3549
1.51
10.46
3.7
3.4
2.4
2.4
mmol/l
0.92
406
3091
1150
10663
2.08
10.42
21.4
16.8
4.0
4.0
mmol/l
0.24
1122
10378
920
8036
1.56
10.40
8.8
7.6
80.1
77.7
u/l
0.70
865
7557
187
1146
1.74
10.24
4.3
4.3
233.1
250.8
u/l
0.79
165
1081
796
6770
1.49
9.96
5.3
4.5
2309.6
2885.8
e6/l
—
5
103
1069
9734
1.71
9.64
17.3
13.3
80.8
80.2
ml/min/173m2
0.40
902
8046
727
6111
1.46
9.38
3.1
2.8
—
—
—
0
0
1039
9415
1.64
9.26
5.6
4.8
1.9
2.0
mu/l
0.57
950
8609
381
2839
1.49
9.13
3.9
3.1
0.3
0.5
e6/l
0.91
288
2165
661
5476
1.44
9.09
6.7
6.3
12.3
11.3
umol/l
0.65
623
5208
892
7862
1.48
8.55
4.7
4.0
14.9
14.8
pmol/l
0.35
813
7144
1198
11395
2.52
8.42
27.7
21.4
134.6
135.4
g/l
1.08
1181
11227
1197
11387
2.48
8.31
27.6
21.3
250.8
249.4
e9/l
0.28
1167
11108
185
1196
1.64
8.23
3.0
2.6
11.5
7.9
umol/l
0.78
158
1051
1197
11393
2.46
8.19
27.6
21.3
4.5
4.5
e12/l
0.76
1162
11080
1197
11395
2.46
8.15
27.6
21.3
6.9
6.7
e9/l
1.54
1158
11083
433
3373
1.44
8.03
3.2
3.3
30.9
32.7
u/l
0.63
410
3208
180
1165
1.64
7.97
2.5
2.6
1.8
1.8
%
0.24
154
1042
715
6096
1.41
7.87
5.4
4.8
6.6
6.7
mmol/l
0.57
679
5723
1090
10091
1.66
7.82
5.1
4.6
6.0
6.0
mmol/l
0.67
990
9182
1066
9838
1.60
7.47
4.4
4.0
1.4
1.3
mmol/l
3.57
966
8994
530
4321
1.40
7.44
3.4
2.7
130.7
137.0
ug/l
0.23
476
3969
1119
10456
1.72
7.43
5.5
5.0
2.7
2.8
mmol/l
0.17
1016
9620
1044
9601
1.55
7.30
6.5
5.8
39.7
39.9
mmol/mol
0.30
970
8897
1161
10977
1.91
7.24
12.9
10.5
26.8
26.2
u/l
0.42
1122
10609
150
949
1.66
7.24
2.4
2.3
36.3
35.7
u/l
0.04
128
795
229
1603
1.53
7.20
2.7
2.4
12.0
13.2
umol/l
1.69
209
1479
356
2727
1.43
7.07
3.0
2.6
2353.9
6188.4
umol/l
1.58
296
2356
408
3208
1.41
6.97
2.3
2.2
172.2
232.7
u/l
1.22
387
3022
267
1951
1.47
6.78
3.1
3.1
2.5
2.5
mmol/l
0.53
228
1710
1098
10257
1.62
6.71
5.0
4.5
4.6
4.7
mmol/l
0.75
1007
9485
211
1474
1.52
6.67
2.7
2.4
2.3
2.3
g/l
0.29
191
1367
194
1333
1.54
6.62
32.5
24.5
1.2
1.3
inr
0.42
20
173
76
408
1.92
6.40
3.1
2.6
8.0
7.4
g/l
1.27
54
312
1090
10190
1.58
6.34
4.9
4.4
1.4
1.5
mmol/l
2.34
989
9365
108
654
1.71
6.15
7.9
9.4
0.6
0.7
%
0.85
108
649
75
407
1.90
6.13
3.1
2.6
3.5
3.7
g/l
0.49
53
297
71
379
1.93
6.09
3.1
2.6
11.0
10.5
g/l
0.20
57
321
75
408
1.89
6.08
3.1
2.6
—
—
—
0
0
72
387
1.91
6.06
3.0
2.7
3.2
3.1
g/l
0.16
53
302
175
1201
1.53
5.99
1.8
1.8
—
—
—
0
0
233
1699
1.46
5.92
1.9
1.9
—
—
—
0
0
61
313
2.00
5.87
2.7
2.7
0.1
0.0
g/l
0.59
55
288
67
356
1.93
5.84
3.3
2.8
1.4
1.4
g/l
0.01
57
316
234
1713
1.45
5.82
3.8
3.3
0.8
0.8
mmol/l
0.35
215
1606
59
301
2.01
5.77
1.6
1.5
265.9
277.2
ug/g
0.16
37
182
284
2163
1.41
5.67
3.1
2.5
4.9
5.7
e6/l
0.38
239
1921
33
133
2.52
5.65
1.3
1.3
—
—
—
0
0
81
463
1.80
5.64
2.1
2.1
40.4
39.4
u/l
0.17
73
412
333
2607
1.38
5.64
2.7
2.1
3.0
3.0
mg/l
0.15
287
2195
62
326
1.95
5.58
2.7
2.6
37.2
37.7
g/l
0.26
51
283
57
292
2.00
5.53
2.7
2.7
0.0
0.0
g/l
0.00
51
269
194
1385
1.48
5.48
2.9
2.4
21.7
23.1
%
0.71
163
1177
57
294
1.98
5.43
2.7
2.7
0.0
0.0
g/l
0.00
51
270
106
662
1.66
5.40
7.9
9.2
1.4
1.3
%
0.19
106
657
377
3028
1.35
5.39
3.1
3.0
1442.8
1221.3
ng/l
0.51
326
2578
767
6825
1.32
5.32
3.2
3.1
56.9
51.4
u/l
0.38
706
6371
403
3276
1.34
5.30
3.7
3.2
7.6
7.5
mmol/l
0.27
341
2750
89
533
1.72
5.30
8.1
10.2
24.5
24.5
mmol/l
0.03
81
499
172
1208
1.49
5.27
1.8
1.8
—
—
—
0
0
482
4028
1.32
5.22
4.0
3.7
23.3
46.9
ng/l
1.94
332
2840
255
1932
1.40
5.21
1.9
1.7
1230.9
1207.1
nmol/l
0.13
181
1450
54
278
1.99
5.18
1.3
1.2
—
—
—
0
0
319
2516
1.36
5.09
2.5
2.4
—
—
—
0
0
925
8492
1.35
4.98
22.9
17.7
13.8
13.7
%
1.11
912
8309
315
2493
1.35
4.89
1.7
1.5
19.8
20.8
nmol/l
0.61
272
2112
169
1204
1.47
4.81
7.2
7.7
5.2
5.1
kpa
0.40
162
1157
169
1205
1.47
4.79
7.2
7.7
12.2
12.2
kpa
0.03
162
1159
133
904
1.53
4.76
2.5
2.5
5.3
7.2
ug/l
1.32
110
811
582
5035
1.29
4.74
4.5
3.7
0.0
0.0
estimate
0.80
83
916
134
915
1.52
4.70
6.9
7.2
9.2
9.8
mmol/l
0.50
127
872
295
2325
1.35
4.69
1.8
1.7
1.1
1.2
mg/l
0.17
227
1789
398
3281
1.31
4.63
4.3
4.0
7.7
8.5
mg/mmol
0.16
252
2054
575
4977
1.29
4.63
4.4
3.7
0.0
0.0
estimate
0.00
85
939
131
893
1.52
4.63
6.5
7.2
1.4
1.4
mmol/l
0.02
121
857
575
4984
1.29
4.56
6.0
5.0
0.0
0.0
estimate
0.50
85
957
212
1592
1.40
4.53
1.5
1.4
—
—
—
0
0
167
1204
1.45
4.47
7.3
7.7
1.1
1.3
mmol/l
0.14
132
948
56
310
1.84
4.38
1.7
1.7
—
—
—
0
0
126
863
1.51
4.36
3.2
3.0
67.1
66.8
g/l
0.13
112
789
96
624
1.58
4.20
1.3
1.3
79.8
50.5
au/ml
—
5
28
43
223
1.96
4.10
1.3
1.5
—
—
—
0
0
75
462
1.66
4.08
1.7
2.0
1.6
1.5
g/l
0.23
61
406
92
600
1.58
3.98
1.5
1.5
—
—
—
0
0
65
388
1.71
3.97
1.2
1.2
0.3
1.2
u/ml
—
9
27
138
982
1.46
3.97
2.8
2.2
0.2
0.2
g/l
0.54
128
917
17
60
2.86
3.80
1.4
2.0
—
—
—
0
0
275
2218
1.31
3.65
4.5
4.0
1.0
1.0
kg/l
0.13
36
311
30
143
2.13
3.61
1.0
1.1
—
—
—
0
0
390
3297
1.27
3.57
2.7
2.5
58.2
57.9
u/l
0.04
359
3057
108
753
1.48
3.46
1.6
1.6
—
—
—
0
0
248
1997
1.30
3.31
4.3
3.8
180.7
393.8
ng/l
1.48
195
1580
127
929
1.41
3.17
4.0
3.4
1.7
2.1
mmol/l
0.53
104
740
72
470
1.56
3.15
4.7
3.5
24.5
24.2
mmol/l
0.36
64
420
161
1228
1.36
3.13
1.7
1.8
1.6
1.5
%
1.00
137
1067
38
210
1.84
3.07
1.6
1.3
—
—
—
0
0
38
210
1.84
3.07
1.6
1.3
—
—
—
0
0
21
94
2.26
2.97
3.1
2.2
—
—
—
0
0
545
4860
1.22
2.92
4.1
4.1
—
—
—
0
0
29
151
1.94
2.81
1.0
1.1
12.4
2.0
u/ml
—
10
57
54
345
1.59
2.63
2.0
2.7
—
—
—
0
0
13
50
2.62
2.53
1.3
1.2
—
—
—
0
0
49
310
1.60
2.50
1.4
1.6
0.0
0.1
iu/ml
0.99
11
56
45
282
1.62
2.40
1.4
1.3
—
—
—
0
0
15
64
2.36
2.39
1.3
1.9
14.2
14.8
%
—
9
29
42
265
1.61
2.20
1.7
1.7
13754.1
13527.8
e6/l
0.01
31
202
50
329
1.54
2.19
1.8
1.9
—
—
—
0
0
108
821
1.35
2.19
2.2
2.6
61.2
65.7
ml/min/173m2
0.53
39
332
6
14
4.30
2.15
1.3
1.4
—
—
—
0
0
7
19
3.70
2.15
1.3
1.1
98.3
100.4
%
—
7
19
7
19
3.70
2.15
1.3
1.1
—
—
—
0
0
20
103
1.96
2.06
6.0
3.7
—
—
—
0
0
150
1206
1.28
2.04
2.7
2.2
169.6
126.4
ug/g
0.43
128
949
167
1372
1.25
1.91
6.4
5.5
1.1
1.0
mmol/l
0.47
154
1262
110
862
1.30
1.84
3.0
2.9
205.1
187.8
ng/l
0.22
96
786
36
230
1.58
1.83
1.3
1.3
1773.2
938.1
e6/l
0.23
31
186
36
230
1.58
1.83
1.3
1.2
18.8
26.5
e6/l
0.20
30
180
199
1675
1.22
1.83
1.3
1.3
14.7
12.8
u/ml
0.12
73
633
60
428
1.42
1.82
2.0
2.0
1.1
2.1
ug/l
0.46
50
382
122
975
1.28
1.77
2.6
2.1
392.2
378.0
nmol/l
0.31
104
899
86
657
1.33
1.73
1.2
1.2
169.9
152.1
iu/ml
0.16
35
264
36
234
1.55
1.72
1.4
1.2
3.7
3.8
mmol/l
0.15
36
223
33
211
1.58
1.69
1.2
1.2
22.5
27.8
u/ml
—
5
16
43
292
1.49
1.69
1.3
1.4
—
—
—
0
0
48
334
1.45
1.68
5.3
3.9
42.9
40.4
mg/l
0.06
43
274
48
334
1.45
1.68
5.3
3.9
41.5
69.0
mg/l
0.77
43
273
16
83
1.94
1.65
1.3
1.3
10.2
12.1
mmol/l
0.67
11
23
39
261
1.51
1.65
1.4
1.3
599.5
504.9
mg/l
0.52
39
249
79
604
1.33
1.60
3.8
3.3
4.3
4.5
pmol/l
0.98
73
525
6
20
3.01
1.58
1.2
1.1
—
—
—
0
0
11
50
2.21
1.57
1.2
1.1
—
—
—
0
0
305
2706
1.17
1.57
5.0
4.0
0.0
0.0
estimate
1.08
84
919
254
2221
1.18
1.56
1.7
1.7
406.6
26023339.1
pmol/l
1.92
207
1833
79
611
1.31
1.49
1.8
1.6
—
—
—
0
0
35
236
1.50
1.45
1.4
1.4
11.3
9.9
u/l
0.27
29
187
56
413
1.37
1.45
2.0
1.9
—
—
—
0
0
33
222
1.50
1.39
2.6
2.2
5192.1
2355.8
u/l
0.31
16
82
14
74
1.90
1.39
1.2
1.9
818.2
801.8
e6/l
—
5
28
422
3864
1.14
1.39
4.7
3.9
—
—
—
0
0
6
23
2.62
1.37
1.5
1.5
—
—
—
0
0
5
17
2.95
1.36
1.8
2.0
19.1
17.7
umol/l
—
5
17
42
299
1.42
1.35
1.6
1.5
—
—
—
0
0
9
42
2.15
1.33
3.0
4.4
—
—
—
0
0
133
1113
1.22
1.33
3.8
4.3
22.9
23.3
ug/l
0.01
103
924
30
200
1.51
1.33
1.3
1.2
—
—
—
0
0
203
1768
1.18
1.32
1.4
1.3
31.8
33.8
iu/ml
0.07
60
561
39
276
1.43
1.30
1.2
1.2
4.7
11.7
u/ml
—
5
47
56
422
1.34
1.29
3.3
3.7
24.7
24.9
mmol/l
0.28
51
398
24
153
1.58
1.29
1.3
1.2
1.4
3.9
u/ml
—
7
42
91
733
1.26
1.29
2.2
2.2
14.4
13.0
nmol/l
0.30
80
648
12
62
1.94
1.28
1.2
1.2
—
—
—
0
0
367
3354
1.13
1.23
5.2
4.9
1.9
2.5
ug/l
2.09
330
3006
36
254
1.43
1.23
1.5
1.3
—
—
—
0
0
248
2211
1.15
1.20
1.3
1.2
2.1
1.7
u/ml
0.20
64
590
6
26
2.31
1.18
1.3
1.9
—
—
—
0
0
31
215
1.45
1.16
1.6
1.6
—
—
—
0
0
15
87
1.73
1.15
1.2
1.4
—
—
—
0
0
5
20
2.51
1.15
1.2
1.2
—
—
—
0
0
18
111
1.63
1.12
1.4
1.2
—
—
—
0
0
20
127
1.58
1.12
1.4
1.8
—
—
—
0
0
8
41
1.96
1.09
1.6
1.7
—
—
—
0
0
41
304
1.36
1.08
1.4
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
32
2.19
1.08
1.3
2.0
133.9
134.1
%
—
7
32
102
852
1.21
1.07
2.3
1.9
—
—
—
0
0
41
305
1.36
1.06
1.4
1.2
—
—
—
0
0
6
123
0.49
1.05
1.7
1.6
—
—
—
0
0
5
22
2.28
1.03
1.4
2.7
—
—
—
0
0
30
214
1.41
1.00
3.4
3.0
0.8
0.9
nmol/l
0.47
23
164
17
107
1.60
1.00
2.2
2.3
—
—
—
0
0
31
223
1.40
0.99
1.1
1.1
—
—
—
0
0
13
76
1.72
0.99
1.2
1.1
—
—
—
0
0
13
76
1.72
0.99
1.2
1.1
—
—
—
0
0
13
77
1.70
0.95
1.2
1.1
—
—
—
0
0
13
77
1.70
0.95
1.2
1.1
—
—
—
0
0
13
77
1.70
0.95
1.2
1.1
—
—
—
0
0
9
51
1.77
0.94
1.0
1.1
—
—
—
0
0
16
101
1.59
0.93
1.4
1.3
—
—
—
0
0
92
774
1.20
0.93
2.1
1.9
—
—
—
0
0
96
811
1.20
0.92
4.3
3.7
99.0
85.6
ng/l
0.99
85
714
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
44
341
1.30
0.90
4.5
2.6
0.3
0.4
u/ml
0.55
22
186
6
29
2.07
0.89
1.0
1.8
—
—
—
0
0
10
56
1.79
0.88
1.2
1.2
—
—
—
0
0
10
56
1.79
0.88
1.3
1.1
—
—
—
0
0
61
495
1.24
0.87
3.0
3.2
25.1
25.3
mmol/l
0.22
61
479
15
95
1.59
0.87
1.3
1.5
—
—
—
0
0
15
227
0.66
0.85
3.2
3.8
23.0
25.4
mg/l
—
10
147
22
154
1.44
0.83
1.2
1.1
—
13.9
—
0
9
6
32
1.88
0.82
1.2
1.2
—
—
—
0
0
8
47
1.71
0.80
1.5
1.2
—
—
—
0
0
6
33
1.82
0.79
1.2
1.2
—
—
—
0
0
33
251
1.32
0.79
1.8
1.8
2.6
5.0
iu/l
—
10
82
60
493
1.23
0.79
1.5
1.3
—
—
—
0
0
11
66
1.67
0.78
1.7
1.8
—
—
—
0
0
27
199
1.36
0.78
1.5
1.7
—
—
—
0
0
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
23
166
1.39
0.76
1.0
1.1
—
—
—
0
0
38
298
1.28
0.74
1.3
1.2
—
—
—
0
0
28
210
1.34
0.74
2.6
3.6
57.3
57.6
%
0.03
28
210
80
682
1.18
0.73
3.1
3.4
5.2
5.2
kpa
0.15
72
639
7
40
1.75
0.71
1.1
1.1
109.5
268.8
iu/ml
—
7
40
27
203
1.34
0.71
2.6
3.3
4.4
4.3
e9/l
0.04
27
203
40
319
1.26
0.70
1.8
1.6
—
—
—
0
0
63
529
1.20
0.69
2.8
2.7
0.2
0.2
e6/l
0.45
63
512
13
85
1.54
0.69
1.2
1.2
0.0
0.8
u/ml
—
7
38
35
275
1.28
0.68
1.5
1.7
—
—
—
0
0
55
456
1.22
0.68
4.2
3.8
48.5
49.1
%
0.06
55
448
20
145
1.39
0.66
1.2
1.1
—
—
—
0
0
11
70
1.58
0.65
1.1
1.0
—
—
—
0
0
7
44
1.59
0.65
1.4
1.1
—
—
—
0
0
41
332
1.24
0.64
2.1
1.8
—
—
—
0
0
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
21
155
1.36
0.63
1.3
1.2
7.0
6.8
u/ml
—
9
64
10
63
1.59
0.62
1.7
1.4
—
—
—
0
0
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
20
265
0.75
0.59
1.5
1.6
—
—
—
0
0
26
331
0.78
0.57
2.0
1.8
—
—
—
0
0
8
54
1.48
0.57
1.0
1.0
—
—
—
0
0
74
644
1.16
0.56
3.0
3.4
1.1
1.9
mmol/l
1.02
56
492
21
274
0.76
0.56
1.1
1.1
—
7.6
—
0
29
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
55
1.46
0.56
1.1
1.1
—
—
—
0
0
10
65
1.54
0.55
1.9
1.6
7.4
6.5
u/l
—
5
34
15
107
1.41
0.55
1.7
1.3
26836.7
95161.1
e6/l
—
6
58
17
126
1.35
0.51
1.4
1.3
8.8
7.8
mmol/l
0.31
12
86
33
269
1.23
0.51
1.4
1.7
—
—
—
0
0
9
65
1.39
0.50
1.2
1.2
—
—
—
0
0
6
41
1.47
0.50
1.3
1.6
—
—
—
0
0
21
162
1.30
0.50
4.6
3.5
1.7
1.5
%
0.09
15
137
24
189
1.28
0.49
1.3
1.2
254.9
278.5
u/ml
0.16
19
108
12
85
1.42
0.47
1.4
1.1
68.0
165.7
titre
—
5
14
7
50
1.40
0.45
1.3
1.1
206.4
503.5
u/l
—
7
45
21
166
1.27
0.43
1.6
1.7
—
—
—
0
0
31
257
1.21
0.43
1.4
1.1
—
—
—
0
0
8
56
1.43
0.42
1.5
1.6
—
—
—
0
0
8
56
1.43
0.42
1.5
1.6
—
—
—
0
0
8
56
1.43
0.42
1.5
1.6
—
—
—
0
0
8
56
1.43
0.42
1.5
1.6
—
—
—
0
0
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
13
96
1.36
0.41
1.3
1.7
—
—
—
0
0
28
231
1.22
0.41
1.4
1.5
60.8
215.8
pmol/l
1.53
28
225
5
33
1.52
0.41
2.2
1.5
19.8
14.4
pmol/l
—
5
26
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
8
59
1.36
0.41
1.6
1.3
—
—
—
0
0
8
59
1.36
0.41
1.6
1.3
—
—
—
0
0
285
2717
1.06
0.39
4.7
4.2
22.0
21.2
%
0.44
131
1303
5
35
1.43
0.39
4.0
1.3
7.9
8.9
ug/l
—
5
35
119
1098
1.09
0.39
3.8
3.3
—
—
—
0
0
46
403
1.15
0.36
2.2
1.9
—
—
—
0
0
19
153
1.25
0.35
2.0
1.5
—
—
—
0
0
6
44
1.37
0.34
1.0
1.0
—
—
—
0
0
42
368
1.15
0.34
2.1
1.7
—
—
—
0
0
6
46
1.31
0.33
1.3
1.7
—
—
—
0
0
6
46
1.31
0.33
1.7
1.3
5.5
6.3
mmol/l
—
6
46
6
46
1.31
0.33
1.3
1.7
—
—
—
0
0
140
1313
1.07
0.32
4.9
4.6
30.4
32.5
%
1.55
85
888
19
155
1.23
0.32
1.5
1.6
—
—
—
0
0
6
47
1.28
0.32
1.3
1.7
—
—
—
0
0
11
143
0.77
0.32
1.1
1.0
—
—
—
0
0
12
154
0.78
0.32
1.7
1.5
—
—
—
0
0
12
92
1.31
0.32
1.0
1.2
—
—
—
0
0
47
418
1.13
0.31
3.9
3.6
769.6
3380.0
u/ml
0.55
42
361
79
856
0.92
0.29
1.6
1.7
—
—
—
0
0
30
260
1.16
0.29
1.4
1.7
—
—
—
0
0
7
57
1.23
0.29
2.1
3.0
—
—
—
0
0
23
195
1.18
0.28
1.4
1.6
—
—
—
0
0
18
149
1.21
0.28
1.2
1.1
—
—
—
0
0
8
65
1.23
0.27
1.5
1.7
—
—
—
0
0
8
65
1.23
0.27
1.5
1.7
—
—
—
0
0
8
66
1.21
0.26
1.1
1.2
—
—
—
0
0
10
77
1.30
0.26
1.4
1.6
—
—
—
0
0
5
74
0.67
0.26
1.0
1.3
—
—
—
0
0
5
75
0.67
0.26
1.0
1.3
—
—
—
0
0
294
2845
1.04
0.25
1.6
1.7
1.5
1.4
mmol/l
0.84
260
2395
54
493
1.10
0.25
1.1
1.0
—
—
—
0
0
9
76
1.19
0.24
1.7
1.5
1.0
1.0
g/l
—
9
76
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
13
106
1.23
0.23
1.1
1.1
—
—
—
0
0
12
97
1.24
0.23
1.1
1.3
—
—
—
0
0
5
40
1.25
0.22
1.2
1.1
1004.6
1683.3
miu/ml
—
5
40
29
257
1.13
0.22
1.8
1.3
259.1
219.5
miu/ml
0.24
17
123
0
11
0.00
0.21
0.0
1.1
—
10.3
—
0
11
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
20
174
1.15
0.19
2.0
1.8
1.4
1.6
mmol/l
0.94
20
169
91
861
1.06
0.19
4.2
3.9
1.2
1.2
mmol/l
0.12
81
754
12
143
0.84
0.18
1.4
1.4
—
—
—
0
0
12
143
0.84
0.18
1.4
1.4
—
—
—
0
0
12
100
1.20
0.18
1.7
1.5
—
—
—
0
0
12
100
1.20
0.18
1.7
1.5
—
—
—
0
0
12
100
1.20
0.18
1.7
1.5
—
—
—
0
0
11
91
1.21
0.17
1.1
1.1
—
—
—
0
0
7
61
1.15
0.17
1.1
6.2
—
74.6
—
0
16
12
142
0.84
0.17
1.4
1.4
—
—
—
0
0
16
138
1.16
0.17
1.4
2.5
33.0
32.7
pg
0.13
16
138
12
142
0.84
0.17
1.4
1.4
—
—
—
0
0
14
120
1.17
0.16
1.5
1.6
—
—
—
0
0
11
92
1.20
0.16
1.2
1.1
—
70.4
—
0
7
35
322
1.09
0.15
1.5
1.4
—
—
—
0
0
13
112
1.16
0.14
1.1
1.1
—
—
—
0
0
15
169
0.89
0.12
1.3
1.5
—
—
—
0
0
13
148
0.88
0.12
1.3
1.5
—
—
—
0
0
28
259
1.08
0.11
2.2
2.4
62.3
77.5
ug/min
0.19
15
153
202
1979
1.02
0.10
2.8
3.0
0.6
0.8
ug/l
3.35
141
1301
5
44
1.14
0.10
1.2
1.6
—
2024630.0
—
0
5
10
87
1.15
0.09
1.2
1.2
—
—
—
0
0
6
56
1.07
0.08
1.2
1.8
—
—
—
0
0
6
56
1.07
0.08
1.2
1.8
—
—
—
0
0
7
66
1.06
0.08
1.1
1.4
—
275.0
—
0
6
15
138
1.09
0.06
2.3
1.3
0.7
0.6
nmol/l
0.41
15
127
24
253
0.95
0.05
3.0
2.9
49.2
33.5
umol/l
0.65
24
212
15
140
1.07
0.04
1.4
1.4
—
—
—
0
0
22
230
0.96
0.03
1.8
2.1
121.9
128.7
g/l
—
10
171
22
229
0.96
0.03
2.4
2.5
14.8
16.0
%
—
8
118
151
1497
1.01
0.02
1.5
1.4
—
—
—
0
0
17
162
1.05
0.02
2.1
2.7
1018.1
30.5
u/ml
0.46
17
155
10
93
1.08
0.02
1.8
1.8
—
—
—
0
0
10
93
1.08
0.02
1.7
1.0
—
—
—
0
0
10
93
1.08
0.02
1.0
1.0
—
—
—
0
0
15
143
1.05
0.01
1.4
1.3
—
—
—
0
0
15
143
1.05
0.01
1.4
1.3
—
—
—
0
0
17
163
1.04
0.01
1.2
1.3
—
—
—
0
0
39
384
1.02
0.00
1.7
1.8
1.6
3.0
mg/l
2.05
29
285
18
176
1.02
0.00
1.4
1.6
—
—
—
0
0
11
111
0.99
0.00
1.6
1.7
—
—
—
0
0
14
141
0.99
0.00
1.4
1.3
—
—
—
0
0
14
141
0.99
0.00
1.4
1.4
—
—
—
0
0
24
245
0.98
0.00
1.4
1.3
—
—
—
0
0
15
155
0.97
0.00
1.5
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
6
62
0.97
0.00
1.2
1.8
—
—
—
0
0
14
140
1.00
0.00
1.4
1.4
—
—
—
0
0
6
61
0.98
0.00
1.5
1.2
33.3
18.4
u/l
—
6
54
5
50
1.00
0.00
1.8
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
6
63
0.95
0.00
1.5
1.2
77.2
76.8
u/l
—
6
57
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
0.00
1.8
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_MOUTH_NOS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MOUTH_NOS | 1.144 [1.02, 1.29] | 0.025 |
| Birth year | 0.995 [0.99, 1.0] | 0.208 |
During the follow-up period (1.1.1998 — 31.12.2019), 610 out of 4031 females with CD2_BENIGN_MOUTH_NOS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MOUTH_NOS | 1.19 [1.05, 1.35] | 0.006 |
| Birth year | 0.992 [0.98, 1.0] | 0.113 |
During the follow-up period (1.1.1998 — 31.12.2019), 636 out of 3156 males with CD2_BENIGN_MOUTH_NOS died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_MOUTH_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.054% | 0.272% |
| 5 | 0.611% | 1.598% |
| 10 | 1.591% | 3.938% |
| 15 | 3.274% | 7.422% |
| 20 | 5.738% | 12.371% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MOUTH_NOS – Benign neoplasm: Other and unspecified parts of mouth
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data